Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche, Bristol Melanoma Drugs Shine
The Street
Sunday, June 5, 2011 - 10:39am
tags:
Roche, Bristol-Myers Squibb, melanoma, vemurafenib, Yervoy
Glaxo’s Melanoma Cocktail Helps Almost All Patients In First Trial
Bloomberg
Sunday, June 5, 2011 - 10:36am
tags:
GSK, melanoma
Pfizer’s Aromasin Blocks Breast Cancer in Healthy, At-Risk Women in Study
Bloomberg
Sunday, June 5, 2011 - 10:32am
tags:
Aromasin, Pfizer, breast cancer
NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil
Yahoo/PR NewsWire
Sunday, June 5, 2011 - 10:30am
tags:
NKTR-102, ovarian cancer, Nektar
Adeona Pharmaceuticals Looks Stronger After Positive Findings
Seeking Alpha
Sunday, June 5, 2011 - 10:29am
tags:
Adeona, reaZin, zinc deficiency, Alzheimer's disease
Final Phase III Data from Study CA031 of ABRAXANE® in Combination with Carboplatin in Patients with Non-Small Cell Lung Cancer Presented at ASCO
Yahoo/BusinessWire
Sunday, June 5, 2011 - 10:26am
tags:
Abraxane, Celgene, carboplatin, non-small cell lung cancer
NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting
Yahoo/PR NewsWire
Sunday, June 5, 2011 - 10:24am
tags:
NKTR-102, breast cancer, Nektar, topoisomerase I inhibitor
SciClone Presents New Preclinical Data Highlighting Potential Role of SCV-07 in Cancer Treatment at 2011 ASCO Annual Meeting
MarketWire
Sunday, June 5, 2011 - 10:22am
tags:
SciClone, SCV-07, cancer, oral mucositis
OXiGENE Reports Encouraging Data From Phase 2 Trial of ZYBRESTAT(TM) in Non-small Cell Lung Cancer
Yahoo/Globe NewsWire
Sunday, June 5, 2011 - 10:07am
tags:
Oxigene, Zybrestat, non-small cell lung cancer
Exelixis Drug Shrinks Ovarian Cancer
The Street
Sunday, June 5, 2011 - 10:06am
tags:
Exelixis, cabozantinib, ovarian cancer
Alnylam Presents Phase I Data for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers, at American Society of Clinical Oncology (ASCO) Meeting
Yahoo/BusinessWire
Sunday, June 5, 2011 - 10:04am
tags:
Alnylam, liver cancer, ALN-VSP, RNAi
Incyte Announces Ruxolitinib (INC424) Shows Significant Clinical Benefit for Myelofibrosis Patients in Two Phase III Studies at ASCO Annual Meeting
Yahoo/BusinessWire
Sunday, June 5, 2011 - 10:03am
tags:
Incyte, ruxolitinib, INC424, myelofibrosis
Corcept Therapeutics Announces Detailed Findings From Phase 3 Study Which Show CORLUX Significantly Improves Clinical and Metabolic Manifestations of Cushing's Syndrome
Yahoo/MarketWire
Sunday, June 5, 2011 - 10:01am
tags:
Corcept Therapeutics, Corlux, Cushing's syndrome
Study Finds Treatment with Metreleptin Improved Diabetes and Lipid Control in Patients with Partial Lipodystrophy
Yahoo/PR NewsWire
Sunday, June 5, 2011 - 9:58am
tags:
metreleptin, diabetes, partial lipodystrophy, Amylin
ASCO '11: Roche, Avastin and Ovarian Cancer
The Street
Sunday, June 5, 2011 - 9:56am
tags:
Roche, Avastin, ovarian cancer
Bionovo's Menerba Phase 2 trial data to be presented at Annual World Congress on Menopause
news-medical.net
Saturday, June 4, 2011 - 11:24am
tags:
Bionovo, Menerba, menopause
'UK pharmaceutical industry in crisis'
Press TV
Saturday, June 4, 2011 - 11:23am
tags:
UK
Mylan receives US FDA nod for generic Effexor XR capsules
Pharmabiz
Saturday, June 4, 2011 - 11:15am
tags:
Mylan, Effexor XR
Tarceva nearly doubled the time people with a genetically distinct type of lung cancer lived without their disease getting worse
Pipeline Review
Saturday, June 4, 2011 - 11:13am
tags:
Tarceva, lung cancer
Takeda Drops Suit Over Macleods' Actos ANDA
Law360
Saturday, June 4, 2011 - 11:06am
tags:
Takeda, Actos, Macleod

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.